Chromatographic Methods for Quantitative Analysis of Native, Denatured, and Aggregated Basic Fibroblast Growth Factor in Solution Formulations

High-performance liquid chromatography (HPLC) methods were developed for evaluating stability of human recombinant basic fibroblast growth factor (bFGF) against denaturation and aggregation in solution formulations. Re versed-phase chromatography (RP-HPLC)-insensitive to bFGF tertiary structure-was used to measure total soluble protein; heparin affinity chromatography (HepTSK) provided quantitative analysis of native bFGF species. The folding state of bFGF was determined by fluorescence spectroscopy: Tryptophan emission, which was quenched in native protein, increased upon unfolding. Slow unfolding/refolding kinetics of bFGF in 2 M guanidine hydrochloride made possible the separation of native from denatured species by size exclusion chromatography (SEC). Although the tertiary structure affected bFGF retention times, it did not change the sample recovery by SEC. These chromatographic techniques, which quantitatively measure physical and chemical changes taking place in solution formulations, can be used in future investigations of bFGF stability.

[1]  D. Gospodarowicz,et al.  Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[3]  J. Fiddes,et al.  Chemical Characterization of the Cysteines of Basic Fibroblast Growth Factor , 1991, Annals of the New York Academy of Sciences.

[4]  M. Herold,et al.  Unfolding of truncated and wild type aspartate aminotransferase studied by size-exclusion chromatography. , 1991, Journal of chromatography.

[5]  R Guillemin,et al.  Receptor- and heparin-binding domains of basic fibroblast growth factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Fiddes,et al.  Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. , 1986, Science.

[7]  E. Stellwagen,et al.  Refolding of denatured ribonuclease observed by size exclusion chromatography. , 1989, Biochemistry.

[8]  Fiddes Jc,et al.  Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing. , 1991 .

[9]  D. Gospodarowicz,et al.  Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.

[10]  B. Matthews,et al.  Three-dimensional structure of human basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. J. Corbett,et al.  Use of high-speed size-exclusion chromatography for the study of protein folding and stability. , 1984, Biochemistry.

[12]  J. Folkman,et al.  Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. , 1987, Proceedings of the National Academy of Sciences of the United States of America.